Immunoassays: Common Errors That Affect Result Accuracy

Immunoassays: Common Errors That Affect Result Accuracy

Immunoassays are essential tools in clinical diagnostics, biopharmaceutical research, and routine laboratory testing, but small procedural errors can compromise accuracy.

For laboratories using immunoassays, reliability depends on disciplined sample handling, stable reagents, controlled incubation, correct washing, and verified instrument performance.

This guide reviews common error sources and practical controls that reduce variability, improve confidence, and support defensible immunoassay results.

Why Immunoassays Need Checklist-Based Control

Immunoassays measure biological interactions, often between antigens and antibodies, under highly specific chemical and physical conditions.

Because these interactions are sensitive, errors may appear as false positives, false negatives, poor precision, or distorted calibration curves.

A checklist approach helps convert complex procedures into repeatable actions, reducing dependence on memory and individual habits.

It also supports traceability when reviewing unexpected immunoassay results, failed quality controls, or lot-to-lot performance changes.

In regulated or high-throughput environments, checklists strengthen consistency without slowing essential laboratory workflows.

Core Checklist for Accurate Immunoassays

The following checklist focuses on actions that directly influence immunoassay accuracy from sample receipt to final data review.

• Confirm sample identity before testing, and verify tube type, collection time, anticoagulant use, and visible hemolysis or lipemia.
• Mix samples gently but completely, avoiding foam, vortex damage, or repeated freeze-thaw cycles that degrade target analytes.
• Store reagents within validated temperature ranges, and document any excursion before continuing with immunoassays.
• Bring reagents and samples to the required temperature, unless the assay protocol specifies cold handling.
• Use calibrated pipettes, matched tips, and consistent pipetting angles to reduce volume-related immunoassay variation.
• Prepare standards carefully, following dilution order, mixing time, and matrix requirements for the calibration curve.
• Control incubation timing with timers, not memory, and apply the same timing pattern across wells or tubes.
• Maintain incubation temperature within specification, because antibody binding kinetics shift when plates warm unevenly.
• Wash plates thoroughly, removing residual liquid without overdrying wells or damaging bound immune complexes.
• Inspect bubbles, droplets, edge effects, and incomplete dispensing before reading optical, fluorescent, or chemiluminescent signals.
• Run controls at defined levels, and reject immunoassay results when controls fail acceptance criteria.
• Review raw data, curve fit, replicate agreement, and flagged values before transferring final results.

Sample Preparation Errors in Immunoassays

Sample quality is one of the most frequent causes of inaccurate immunoassays.

Problems can begin before the specimen reaches the analytical bench.

Incorrect collection tubes may introduce additives that interfere with antibody binding or signal generation.

Hemolysis can release intracellular components, while lipemia may scatter light or affect automated aspiration.

Delayed processing may alter unstable analytes, especially hormones, cytokines, cardiac markers, and inflammatory proteins.

Freeze-thaw damage is another practical concern in immunoassays used for research biobanks.

Each thaw may denature proteins, concentrate salts, or increase particulate material.

Aliquoting samples during initial processing reduces future degradation and supports more consistent longitudinal comparisons.

Reagent Storage and Lot Variation

Immunoassays rely on reagents that may lose activity when exposed to heat, light, contamination, or repeated opening.

Enzyme conjugates, labeled antibodies, magnetic particles, substrates, and calibrators require careful storage discipline.

A reagent that appears normal may still produce weak signal, high background, or poor curve separation.

Lot changes also deserve attention, even when supplied by the same manufacturer.

New lots should be verified against current lots using controls, representative samples, and clinically relevant decision points.

For critical immunoassays, lot bridging helps detect bias before patient data or research conclusions are affected.

Pipetting, Dilution, and Plate Layout Mistakes

Small pipetting errors can become large analytical errors in immunoassays, particularly at low analyte concentrations.

Uncalibrated pipettes, worn seals, poor pre-wetting, or inconsistent plunger speed all influence delivered volume.

Serial dilution errors can distort the entire standard curve.

One incorrect transfer may make downstream points appear precise but mathematically wrong.

Plate layout errors are equally disruptive.

Misplaced standards, duplicated samples in the wrong wells, or skipped controls may invalidate otherwise well-executed immunoassays.

Printed maps, barcode tracking, or electronic worksheets reduce transcription and placement mistakes.

Incubation Timing and Temperature Control

Binding reactions in immunoassays depend on time and temperature.

Short incubation may produce weak signal, while excessive incubation can increase nonspecific binding.

Temperature gradients across plates may create edge effects that mimic biological differences.

This is common near air vents, windows, heating blocks, or uneven incubator shelves.

For manual immunoassays, staggered addition creates timing differences between the first and last wells.

Multichannel pipettes, consistent row order, and synchronized timers help control this source of variation.

Washing Errors and High Background

In many immunoassays, washing separates bound analyte from unbound materials.

Incomplete washing often causes high background, poor sensitivity, and reduced signal-to-noise ratio.

Overly aggressive washing may detach bound complexes, scratch wells, or create inconsistent residual volumes.

Automated washers require routine checks for clogged needles, correct aspiration height, dispense accuracy, and residual volume.

Manual washing requires consistent soak time, complete inversion, and controlled tapping on absorbent material.

Wash buffer preparation also matters.

Incorrect concentration, microbial contamination, or missing surfactant can change background behavior across immunoassays.

Instrument Calibration and Signal Reading

Even perfectly prepared immunoassays can fail if the reader or analyzer is not performing correctly.

Plate readers, luminometers, fluorescence systems, and automated IVD analyzers require scheduled maintenance and verification.

Optical alignment, lamp intensity, detector stability, filter condition, and temperature control can all influence measured signal.

For automated immunoassays, probe carryover, clot detection, cuvette integrity, and software flags must be reviewed.

Calibration curves should not be accepted by appearance alone.

Review back-calculated standards, residuals, curve model selection, and control recovery before reporting results.

Scenario Notes for Different Immunoassay Applications

Clinical Diagnostics

Clinical immunoassays often support decisions for infection, fertility, thyroid function, cardiac markers, oncology, and therapeutic drug monitoring.

Because results may guide immediate care, laboratories need strict control rules, delta checks, and clear repeat-testing criteria.

Biopharmaceutical Research

In drug development, immunoassays are used for pharmacokinetics, immunogenicity, biomarker quantification, and potency testing.

Matrix effects, anti-drug antibodies, hook effect, and reagent comparability should be assessed during method development.

Point-of-Care Testing

Point-of-care immunoassays prioritize speed and accessibility, but environmental control can be weaker than central laboratories.

Temperature exposure, operator training, cartridge storage, and internal control review are essential for dependable near-patient testing.

Commonly Overlooked Risks

Heterophile antibodies: These antibodies may bridge assay antibodies and create false signals, especially in sandwich immunoassays.

High-dose hook effect: Extremely high analyte levels can produce falsely low results when capture and detection antibodies become saturated.

Biotin interference: Some streptavidin-biotin immunoassays are vulnerable to supplements, producing falsely high or low results depending on format.

Matrix mismatch: Standards prepared in buffer may not behave like serum, plasma, urine, saliva, or cell culture media.

Edge effects: Uneven evaporation or temperature exposure can make outer wells differ from inner wells without true biological cause.

Software assumptions: Automatic curve fitting can hide poor standards, outliers, or results outside the validated measuring range.

Practical Execution Recommendations

1. Create a run-start checklist covering sample status, reagent lot, instrument readiness, plate map, controls, and required environmental conditions.
2. Define acceptance rules before testing, including control recovery, replicate variation, calibration performance, and repeat limits.
3. Document deviations immediately, including delayed incubation, temperature excursions, bubbles, washer alarms, or unexpected instrument flags.
4. Trend quality control data over time to detect drift before immunoassay results move outside specifications.
5. Train all operators using the same procedure, then verify competency through observed runs and data review.
6. Review failed runs as process signals, not isolated events, and identify whether the root cause was procedural, reagent, sample, or instrument related.

Standard operating procedures should be short enough to use, yet detailed enough to prevent improvisation.

Where possible, critical steps should include exact times, volumes, temperatures, mixing actions, and acceptance thresholds.

For laboratories scaling immunoassays, automation can reduce manual variation but does not eliminate the need for verification.

Automated systems still require preventive maintenance, consumable checks, carryover assessment, and periodic comparison with established methods.

Summary and Next Steps

Accurate immunoassays depend on control of many small actions rather than one single corrective measure.

Sample integrity, reagent stability, pipetting precision, incubation discipline, washing quality, and instrument verification all shape final results.

The most effective next step is to audit one complete immunoassay workflow from receipt to report.

Identify where errors could enter, assign control points, and convert those controls into a practical bench-level checklist.

With routine review and documented corrective action, immunoassays can deliver more consistent, transparent, and decision-ready data.